{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:14:42Z","timestamp":1790799282082,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":59,"publisher":"Springer New York","isbn-type":[{"value":"9781493973736","type":"print"},{"value":"9781493973743","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7374-3_2","type":"book-chapter","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T07:08:50Z","timestamp":1508828930000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy"],"prefix":"10.1007","author":[{"given":"Takeshi","family":"Tsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE (1991) Population frequencies of inherited neuromuscular diseases \u2013 a world survey. Neuromuscul Disord 1:19\u201329","journal-title":"Neuromuscul Disord"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N (2014) A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 24:482\u2013491","journal-title":"Neuromuscul Disord"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri E, Muntoni F (2013) Muscular dystrophies. Lancet 381:845\u2013860","journal-title":"Lancet"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77\u201393","journal-title":"Lancet Neurol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/archdischild-2014-307962","volume":"100","author":"EM Strehle","year":"2015","unstructured":"Strehle EM, Straub V (2015) Recent advances in the management of Duchenne muscular dystrophy. Arch dis child 100:1173\u20131177","journal-title":"Arch dis child"},{"issue":"Pt 1","key":"2_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/brain\/awf012","volume":"125","author":"JL Anderson","year":"2002","unstructured":"Anderson JL, Head SI, Rae C, Morley JW (2002) Brain function in Duchenne muscular dystrophy. Brain 125(Pt 1):4\u201313","journal-title":"Brain"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.neubiorev.2013.03.016","volume":"37","author":"WM Snow","year":"2013","unstructured":"Snow WM, Anderson JE, Jakobson LS (2013) Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav rev 37:743\u2013752","journal-title":"Neurosci Biobehav rev"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177\u2013189","journal-title":"Lancet Neurol"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.pcl.2015.03.008","volume":"62","author":"N Wein","year":"2015","unstructured":"Wein N, Alfano L, Flanigan KM (2015) Genetics and emerging treatments for Duchenne and Becker muscular dystrophy. Pediatr Clin North Am 62:723\u2013742","journal-title":"Pediatr Clin North Am"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731\u2013740","journal-title":"Lancet Neurol"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nmd.2012.09.002","volume":"23","author":"A Ferlini","year":"2013","unstructured":"Ferlini A, Neri M, Gualandi F (2013) The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice. Neuromuscul Disord 23:4\u201314","journal-title":"Neuromuscul Disord"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","volume":"71","author":"GQ Wallace","year":"2009","unstructured":"Wallace GQ, McNally EM (2009) Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol 71:37\u201357","journal-title":"Annu Rev Physiol"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ncl.2014.05.002","volume":"32","author":"KM Flanigan","year":"2014","unstructured":"Flanigan KM (2014) Duchenne and Becker muscular dystrophies. Neurol Clin 32:671\u2013688","journal-title":"Neurol Clin"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-0035-1558982","volume":"35","author":"JF Brandsema","year":"2015","unstructured":"Brandsema JF, Darras BT (2015) Dystrophinopathies. Semin Neurol 35:369\u2013384","journal-title":"Semin Neurol"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/humu.21114","volume":"30","author":"KM Flanigan","year":"2009","unstructured":"Flanigan KM, Dunn DM, von Niederhausern A et al (2009) Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat 30:1657\u20131666","journal-title":"Hum Mutat"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","volume":"30","author":"S Tuffery-Giraud","year":"2009","unstructured":"Tuffery-Giraud S, Beroud C, Leturcq F et al (2009) Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat 30:934\u2013945","journal-title":"Hum Mutat"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/0735-1097(93)90781-U","volume":"22","author":"P Melacini","year":"1993","unstructured":"Melacini P, Fanin M, Danieli GA et al (1993) Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol 22:1927\u20131934","journal-title":"J Am Coll Cardiol"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0002-8703(96)90250-1","volume":"132","author":"M Saito","year":"1996","unstructured":"Saito M, Kawai H, Akaike M, Adachi K, Nishida Y, Saito S (1996) Cardiac dysfunction with Becker muscular dystrophy. Am Heart J 132:642\u2013647","journal-title":"Am Heart J"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","volume":"155","author":"DM Connuck","year":"2008","unstructured":"Connuck DM, Sleeper LA, Colan SD et al (2008) Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 155:998\u20131005","journal-title":"Am Heart J"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0828-282X(08)70686-X","volume":"24","author":"J Finsterer","year":"2008","unstructured":"Finsterer J, Stollberger C (2008) Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 24:786\u2013792","journal-title":"Can J Cardiol"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","volume":"87","author":"JA Towbin","year":"1993","unstructured":"Towbin JA, Hejtmancik JF, Brink P et al (1993) X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87:1854\u20131865","journal-title":"Circulation"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/hrt.2003.023390","volume":"90","author":"N Cohen","year":"2004","unstructured":"Cohen N, Muntoni F (2004) Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 90:835\u2013841","journal-title":"Heart"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jacc.2011.01.072","volume":"58","author":"M Diegoli","year":"2011","unstructured":"Diegoli M, Grasso M, Favalli V et al (2011) Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 58:925\u2013934","journal-title":"J Am Coll Cardiol"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","volume":"61","author":"G Schram","year":"2013","unstructured":"Schram G, Fournier A, Leduc H et al (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948\u2013954","journal-title":"J Am Coll Cardiol"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ppul.22688","volume":"48","author":"GM Buyse","year":"2013","unstructured":"Buyse GM, Goemans N, van den Hauwe M, Meier T (2013) Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Pediatr Pulmonol 48:912\u2013920","journal-title":"Pediatr Pulmonol"},{"key":"2_CR26","doi-asserted-by":"publisher","unstructured":"Tandon A, Villa CR, Hor KN et al (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. J Am Heart Assoc. doi:\n                    10.1161\/JAHA.114.001338","DOI":"10.1161\/JAHA.114.001338"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1212\/WNL.41.12.1874","volume":"41","author":"GM Fenichel","year":"1991","unstructured":"Fenichel GM, Florence JM, Pestronk A et al (1991) Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41:1874\u20131877","journal-title":"Neurology"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/mus.880150512","volume":"15","author":"F Shapiro","year":"1992","unstructured":"Shapiro F, Sethna N, Colan S, Wohl ME, Specht L (1992) Spinal fusion in Duchenne muscular dystrophy: a multidisciplinary approach. Muscle Nerve 15:604\u2013614","journal-title":"Muscle Nerve"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1469-8749.2002.tb00272.x","volume":"44","author":"DG McDonald","year":"2002","unstructured":"McDonald DG, Kinali M, Gallagher AC, Mercuri E, Muntoni F, Roper H, Jardine P, Jones DH, Pike MG (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev med child Neurol 44:695\u2013698","journal-title":"Dev med child Neurol"},{"issue":"1125\u20131139","key":"2_CR30","first-page":"xii","volume":"16","author":"JO Benditt","year":"2005","unstructured":"Benditt JO, Boitano L (2005) Respiratory support of individuals with Duchenne muscular dystrophy: toward a standard of care. Phys Med Rehabil Clin N Am 16(1125\u20131139):xii","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2_CR31","first-page":"1475","volume":"11","author":"A LoMauro","year":"2015","unstructured":"LoMauro A, D'Angelo MG, Aliverti A (2015) Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Ther Clin Risk Manag 11:1475\u20131488","journal-title":"Ther Clin Risk Manag"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/01241398-198307000-00014","volume":"3","author":"LT Kurz","year":"1983","unstructured":"Kurz LT, Mubarak SJ, Schultz P, Park SM, Leach J (1983) Correlation of scoliosis and pulmonary function in Duchenne muscular dystrophy. J Pediatr Orthop 3:347\u2013353","journal-title":"J Pediatr Orthop"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1378\/chest.94.6.1232","volume":"94","author":"A Szeinberg","year":"1988","unstructured":"Szeinberg A, Tabachnik E, Rashed N et al (1988) Cough capacity in patients with muscular dystrophy. Chest 94:1232\u20131235","journal-title":"Chest"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1378\/chest.112.4.1024","volume":"112","author":"JR Bach","year":"1997","unstructured":"Bach JR, Ishikawa Y, Kim H (1997) Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 112:1024\u20131028","journal-title":"Chest"},{"key":"2_CR35","first-page":"332","volume":"4","author":"M Polat","year":"2012","unstructured":"Polat M, Sakinci O, Ersoy B, Sezer RG, Yilmaz H (2012) Assessment of sleep-related breathing disorders in patients with duchenne muscular dystrophy. J Clin Med Res 4:332\u2013337","journal-title":"J Clin Med Res"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s11325-014-1103-9","volume":"19","author":"KT Nozoe","year":"2015","unstructured":"Nozoe KT, Moreira GA, Tolino JR, Pradella-Hallinan M, Tufik S, Andersen ML (2015) The sleep characteristics in symptomatic patients with Duchenne muscular dystrophy. Sleep Breath 19:1051\u20131056","journal-title":"Sleep Breath"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1164\/rccm.2105118","volume":"165","author":"RS Amin","year":"2002","unstructured":"Amin RS, Kimball TR, Bean JA et al (2002) Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165:1395\u20131399","journal-title":"Am J Respir Crit Care Med"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/thx.2007.094904","volume":"64","author":"JY Chan","year":"2009","unstructured":"Chan JY, Li AM, Au CT et al (2009) Cardiac remodelling and dysfunction in children with obstructive sleep apnoea: a community based study. Thorax 64:233\u2013239","journal-title":"Thorax"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","volume":"131","author":"EM McNally","year":"2015","unstructured":"McNally EM, Kaltman JR, Benson DW et al (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, lung, and blood institute in collaboration with parent project muscular dystrophy. Circulation 131:1590\u20131598","journal-title":"Circulation"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.med.58.011706.144703","volume":"58","author":"EM McNally","year":"2007","unstructured":"McNally EM (2007) New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annu Rev Med 58:75\u201388","journal-title":"Annu Rev Med"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533\u20132546","journal-title":"J Am Coll Cardiol"},{"key":"2_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004347","volume":"4","author":"I Desguerre","year":"2009","unstructured":"Desguerre I, Christov C, Mayer M et al (2009) Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One 4:e4347","journal-title":"PLoS One"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1536\/ihj.28.687","volume":"28","author":"S Matsuoka","year":"1987","unstructured":"Matsuoka S, Ii K, Akita H et al (1987) Clinical features and cardiopulmonary function of patients with atrophic heart in Duchenne muscular dystrophy. Jpn Heart J 28:687\u2013694","journal-title":"Jpn Heart J"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3345\/kjp.2014.57.5.232","volume":"57","author":"TH Lee","year":"2014","unstructured":"Lee TH, Eun LY, Choi JY et al (2014) Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy. Korean J Pediatr 57:232\u2013239","journal-title":"Korean J Pediatr"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.22097","volume":"44","author":"CF Spurney","year":"2011","unstructured":"Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8\u201319","journal-title":"Muscle Nerve"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00246-012-0281-0","volume":"33","author":"TO Thomas","year":"2012","unstructured":"Thomas TO, Morgan TM, Burnette WB, Markham LW (2012) Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy. Pediatr Cardiol 33:1175\u20131179","journal-title":"Pediatr Cardiol"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1067\/mhj.2001.114804","volume":"141","author":"GA Lanza","year":"2001","unstructured":"Lanza GA, Dello Russo A, Giglio V et al (2001) Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J 141:808\u2013812","journal-title":"Am Heart J"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1532-429X-15-107","volume":"15","author":"KN Hor","year":"2013","unstructured":"Hor KN, Taylor MD, Al-Khalidi HR et al (2013) Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson 15:107","journal-title":"J Cardiovasc Magn Reson"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.104.528281","volume":"112","author":"JL Jefferies","year":"2005","unstructured":"Jefferies JL, Eidem BW, Belmont JW et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799\u20132804","journal-title":"Circulation"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","volume":"45","author":"D Duboc","year":"2005","unstructured":"Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM (2005) Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 45:855\u2013857","journal-title":"J Am Coll Cardiol"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","volume":"2","author":"MC Silva","year":"2016","unstructured":"Silva MC, Magalhaes TA, Meira ZM et al (2016) Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol 2:190\u2013199. doi:\n                    10.1001\/jamacardio.2016.4801","journal-title":"JAMA Cardiol"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","volume":"18","author":"LW Markham","year":"2008","unstructured":"Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH (2008) Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 18:365\u2013370","journal-title":"Neuromuscul Disord"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","volume":"163","author":"BJ Barber","year":"2013","unstructured":"Barber BJ, Andrews JG, Lu Z et al (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr 163:1080\u20131084.e1","journal-title":"J Pediatr"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ng0493-283","volume":"3","author":"AH Ahn","year":"1993","unstructured":"Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nat Genet 3:283\u2013291","journal-title":"Nat Genet"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neubiorev.2015.01.023","volume":"51","author":"RG Hendriksen","year":"2015","unstructured":"Hendriksen RG, Hoogland G, Schipper S, Hendriksen JG, Vles JS, Aalbers MW (2015) A possible role of dystrophin in neuronal excitability: a review of the current literature. Neurosci Biobehav Rev 51:255\u2013262","journal-title":"Neurosci Biobehav Rev"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nmd.2013.01.011","volume":"23","author":"M Pane","year":"2013","unstructured":"Pane M, Messina S, Bruno C et al (2013) Duchenne muscular dystrophy and epilepsy. Neuromuscul Disord 23:313\u2013315","journal-title":"Neuromuscul Disord"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.dhjo.2016.10.002","volume":"10","author":"S Lindsay","year":"2017","unstructured":"Lindsay S, McAdam L, Mahendiran T (2017) Enablers and barriers of men with Duchenne muscular dystrophy transitioning from an adult clinic within a pediatric hospital. Disabil Health J 10:73\u201379","journal-title":"Disabil Health J"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nmd.2014.09.001","volume":"25","author":"M Yamaguchi","year":"2015","unstructured":"Yamaguchi M, Suzuki M (2015) Becoming a back-up carer: parenting sons with Duchenne muscular dystrophy transitioning into adulthood. Neuromuscul Disord 25:85\u201393","journal-title":"Neuromuscul Disord"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nmd.2012.08.009","volume":"23","author":"DG Schrans","year":"2013","unstructured":"Schrans DG, Abbott D, Peay HL et al (2013) Transition in Duchenne muscular dystrophy: an expert meeting report and description of transition needs in an emergent patient population: (parent project muscular dystrophy transition expert meeting 17\u201318 June 2011, Amsterdam, The Netherlands). Neuromuscul Disord 23:283\u2013286","journal-title":"Neuromuscul Disord"}],"container-title":["Methods in Molecular Biology","Duchenne Muscular Dystrophy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7374-3_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T03:39:58Z","timestamp":1558064398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7374-3_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"ISBN":["9781493973736","9781493973743"],"references-count":59,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7374-3_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"assertion":[{"value":"25 October 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}